FDA Denial of Ampligen Exposes Out of Touch Agency; Hemispherx to Appeal
Hemispherx released a statement on Monday indicating the FDA had denied their application of Ampligen to treat Chronic Fatigue Syndrome (ME/CFS) because of a lack of ‘substantial’ proof of efficacy and (rather ominously) because they did not have enough...
Hunger Striker Decries FDA Denial of Only Medicine for Chronic Fatigue Syndrome
Ask Secretary Sebelius to start NIH Clinical Trial of Ampligen Contact: Robert Miller 703-554-5575, Courtney Miller 631-834-4681 In day 8 of his hunger strike, Chronic Fatigue Syndrome patient Robert Miller decried the FDA’s decision (announced hours ago) to...FDA Advisory Committee Meeting on Ampligen and Chronic Fatigue Syndrome (ME/CFS) Pt: II: the VOTE and Aftermath
Check out Part I of this series (‘FDA Advisory Committee Meeting on Ampligen Pt I: Dueling Presentation Set Stage for Critical Vote’) on the Simmaron Foundations Website here The Vote While the FDA statistical team was highly critical of the drug, the FDA...Rituximab Watch
Norway Says ‘No Go’ to Further Fluge/Mella Rituximab Funding It’s kind of inexplicable. Fluge and Mella put Norway on the map of the chronic fatigue syndrome community in a big way, and stimulated interest and efforts from the US to Australia yet the...
Stimulating Results in Vyvanse Chronic Fatigue Syndrome (ME/CFS) Treatment Trial
When people with ME/CFS say they’re not the same person they used to be, it’s not just physical illness they’re talking about it; for many the ‘mental component’; the loss of sharpness, of focus, of the ‘cognitive grace’ they...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
